Phoenix Precision Oncology Conference: Evidence to Practice

Scottsdale, AZ US
September 27, 2025

This accredited continuing education activity, Phoenix Precision Oncology Conference: Evidence to Practice, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties. 

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

ORGANIZING COMMITTEE: 

Course Director:

Binay Shah, MD, MHA - Binaytara 

Conference Chair:

Yousef Zakharia, MD - Mayo Clinic

Tibor Kovacsovics, MD - City Of Hope

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Identify common molecular abnormalities across several prevalent malignancies and review the appropriate timing of testing to detect these abnormalities.
  • Interpret results of next-generation sequencing and other predictive biomarkers to assess responses to targeted therapies, while recognizing associated challenges.
  • Develop optimal molecular-targeted treatment strategies for the management of patients with cancer.
  • Summarize emerging research, mechanisms of action, and roles of novel molecular-targeted therapies in the clinical investigation of cancer patients.
Course summary
Course opens: 
06/20/2025
Course expires: 
12/27/2025
Event starts: 
09/27/2025 - 8:00am PDT
Event ends: 
09/27/2025 - 4:30pm PDT
Cost:
$350.00

Saturday, September 27, 2025

All times are listed in Mountain Standard Time (MST)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:05 AM  Welcome

08:05 AM – 08:25 AM  Binaytara's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:25 AM – 09:25 AM  Session 1 - GI Oncology

Session Chair: Christina S. Wu, MB, B.Ch., MD

08:25 AM – 08:40 AM  Genomics in GI Cancers

08:40 AM – 09:25 AM  Case-Based Discussion: GI Oncology


09:25 AM – 10:25 AM  Session 2 - Breast Cancer

Session Chair: Qing Zhao, MD

09:25 AM – 09:40 AM  Genomics in Breast Cancer  

09:40 AM – 10:25 AM  Case-Based Discussion: Breast Cancer 


10:25 AM – 10:55 AM  Break & Exhibits


10:55 AM – 11:55 AM  Session 3 - GU Oncology

Session Chair: 

10:55 AM – 11:10 AM  Genomics in GU Cancer 

11:10 AM – 11:55 AM  Case-Based Discussion : GU Oncology


11:55 AM – 12:55 PM  Session 4 - Lung Cancer

Session Chair: Jixin Niu, MD

11:55 AM – 12:10 PM  Genomics in Lung Cancer

12:10 PM – 12:55 PM  Case-Based Discussion: Lung Cancer


12:55 PM – 01:55 PM  Lunch & Exhibits


01:55 PM – 03:25 PM  Session 5 - Hematology

Session Chair: Tibor Kovacsovics, MD ; Jeremy T. Larsen, MD

01:55 PM – 02:10 PM  Current Genomics in Multiple Myeloma - Jonathan Keats, PhD

02:10 PM – 02:25 PM  Case-Based Discussion: Multiple Myeloma 

02:25 PM – 02:40 PM  Genomics in Myeloid Disorders

02:40 PM – 02:55 PM  Case-Based Discussion: Myeloid Disorders

02:55 PM – 03:10 PM  Genomics in Lymphoma/CLL

03:10 PM – 03:25 PM  Case-Based Discussion: Lymphoma/CLL


​​​​​03:25 PM  Adjourn

Hilton Scottsdale Resort & Villas
6333 N Scottsdale Rd
Scottsdale, AZ 85250
United States

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

 

Session Chair(s)

Jeremy Larsen

has a financial relationship (Independent contractor) with Janssen Oncology/J&J;.
has a financial relationship (Independent contractor) with BMS;.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.